Medpace Holdings Raises FY2026 GAAP EPS Guidance from $16.68-$17.50 to $17.25-$17.95 vs $16.97 Est; Raises FY2026 Sales Guidance from $2.755B-$2.855B to $2.805B-$2.885B vs $2.778B Est

뉴스 본문을 불러오고 있어요.

Medpace Holdings Raises FY2026 GAAP EPS Guidance from $16.68-$17.50 to $17.25-$17.95 vs $16.97 Est; Raises FY2026 Sales Guidance from $2.755B-$2.855B to $2.805B-$2.885B vs $2.778B Est | 웨이프 WAPE

Medpace Holdings Raises FY2026 GAAP EPS Guidance from $16.68-$17.50 to $17.25-$17.95 vs $16.97 Est; Raises FY2026 Sales Guidance from $2.755B-$2.855B to $2.805B-$2.885B vs $2.778B Est

기사 요약

관련 종목

댓글 —